Next Article in Journal
Halogen-Substituted Triazolethioacetamides as a Potent Skeleton for the Development of Metallo-β-Lactamase Inhibitors
Next Article in Special Issue
Design and Synthesis of Benzimidazole-Chalcone Derivatives as Potential Anticancer Agents
Previous Article in Journal
Speciation of Chromium in Alkaline Soil Extracts by an Ion-Pair Reversed Phase HPLC-ICP MS Method
Previous Article in Special Issue
Design, Synthesis, and Molecular Docking Study of Novel Heterocycles Incorporating 1,3,4-Thiadiazole Moiety as Potential Antimicrobial and Anticancer Agents
Open AccessArticle

Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives as Antiproliferative Agents

Institute of Drug Synthesis and Pharmaceutical Process, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
*
Authors to whom correspondence should be addressed.
Academic Editor: Jean Jacques Vanden Eynde
Molecules 2019, 24(6), 1173; https://doi.org/10.3390/molecules24061173
Received: 16 February 2019 / Revised: 18 March 2019 / Accepted: 20 March 2019 / Published: 25 March 2019
Inspired by the potent inhibition activity of the c-Met (mesenchymal−epithelial transition factor) inhibitor Tepotinib, a series of new Tepotinib derivatives were synthesized and evaluated for their ability to act as antiproliferative agents to find the leading compounds with good activity and limited side effects. Among them, compound 31e exhibited potent antiproliferative activity (IC50 (50% inhibitory concentration) = 0.026 μΜ) against hepatic carcinoma 97H (human liver cancer cell) cells and, importantly, had very low inhibitory activity against normal cells. A mechanism study demonstrated that 31e induced G1 phase (First growth phase or G indicating gap) arrest, inhibited the phosphorylation of c-Met and its downstream signaling component, Akt (Protein Kinase B), and also inhibited the migration of hepatic carcinoma 97H cells. View Full-Text
Keywords: antiproliferative agents; c-Met inhibitor; 97H cells; low toxicity antiproliferative agents; c-Met inhibitor; 97H cells; low toxicity
Show Figures

Graphical abstract

MDPI and ACS Style

Zhang, N.-n.; An, B.-j.; Zhou, Y.; Li, X.-s.; Yan, M. Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives as Antiproliferative Agents. Molecules 2019, 24, 1173. https://doi.org/10.3390/molecules24061173

AMA Style

Zhang N-n, An B-j, Zhou Y, Li X-s, Yan M. Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives as Antiproliferative Agents. Molecules. 2019; 24(6):1173. https://doi.org/10.3390/molecules24061173

Chicago/Turabian Style

Zhang, Niu-niu; An, Bai-jiao; Zhou, Yan; Li, Xing-shu; Yan, Ming. 2019. "Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives as Antiproliferative Agents" Molecules 24, no. 6: 1173. https://doi.org/10.3390/molecules24061173

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop